Baijin Life Science Holdings Limited (HKG:1466)

Hong Kong · Delayed Price · Currency is HKD

0.6200

+0.0700 (12.73%)

Jun 18, 2026, 3:59 PM HKT

-10.14% (1Y)

Market Cap	578.00M +6.9%
Revenue (ttm)	119.80M +20.5%
Net Income	8.08M
EPS	0.01
Shares Out	932.25M
PE Ratio	61.89
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,775,999
Open	0.5500
Previous Close	0.5500
Day's Range	0.5500 - 0.6400
52-Week Range	0.4650 - 0.7200
Beta	-0.26
Analysts	n/a
Price Target	n/a
Earnings Date	Jun 30, 2026

About HKG:1466

Baijin Life Science Holdings Limited, an investment holding company, engages in the purchase, processing, design, production, assembly, trading, and wholesale distribution of jewelry products. The company operates through three segments: Jewellery Business, Strategic Investment, and Skincare Business. It is involved in the real estate financial assets investment business. The company also offers skincare solutions under the FO brand name; franchise licensing and consultation services; consultation and research and development services; skincare... [Read more]

Industry Luxury Goods

Sector Consumer Discretionary

Founded 2014

Employees 79

Stock Exchange Hong Kong Stock Exchange

Ticker Symbol 1466

Full Company Profile

Financial Performance

In fiscal year 2025, HKG:1466's revenue was 135.56 million, an increase of 152.54% compared to the previous year's 53.68 million. Losses were -316,000, -95.76% less than in 2024.

Financial Statements